[MDGL] QoQ Quarter Result on 30-Sep-2012 [#Q3]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
06-Nov-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- -2.57%
YoY- -17.76%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Revenue 0 0 7,437 0 0 147 3,423 -
PBT -22,787 -20,728 -47,380 -14,996 -14,620 -15,051 -47,380 -38.64%
Tax 0 0 -44,667 0 0 0 -36,637 -
NP -22,787 -20,728 -18,123 -14,996 -14,620 -15,051 -10,743 65.16%
Tax Rate - - - - - - - -
Total Cost 22,787 20,728 25,560 14,996 14,620 15,198 14,166 37.32%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
NP Margin 0.00 0.00 -243.69 0.00 0.00 -10,238.78 -313.85 -
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
EPS -11.55 -10.52 -9.19 -8.65 -8.88 -9.35 -6.67 44.25%
EPS Diluted -11.55 -10.52 -9.19 -8.65 -8.88 -9.35 -6.67 44.25%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.